Arbutus Biopharma Corp (NASDAQ:ABUS)
| 1.93 Delayed Data As of Sep 23 |  -0.03 / -1.53%Today’s Change | 1.85 Today|||52-Week Range 6.50 | -50.39% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $346.4M |
Company Description
Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
Contact Information
Arbutus Biopharma Corp. 701 Veterans Circle Warminster Pennsylvania 18974 |
Employees
Shareholders
| Mutual fund holders | 9.96% |
| Other institutional | 19.62% |
| Individual stakeholders | 13.25% |
Top Executives
| William H. Collier | President, Chief Executive Officer & Director |
| David C. Hastings | Chief Financial & Accounting Officer |
| Michael J. Sofia | Chief Scientific Officer |
| Elizabeth Howard | Secretary, Chief Compliance Officer & EVP |
| Michael J. McElhaugh | Chief Business Officer |
